Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Center For International Blood And Marrow Transplant Research

Clinical trials sponsored by Center For International Blood And Marrow Transplant Research, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Lower drug dose after transplant may cut infections without losing protection Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1 Terminated 1

New pill aims to keep leukemia away after transplant

Disease control Not yet recruiting

This study tests a new oral drug called revumenib in people with acute myeloid leukemia (AML) who have certain genetic changes. After a stem cell transplant, participants will take revumenib or a placebo to see if it helps keep the cancer from coming back. The trial involves 144 …

Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC